Teilnahme an klinischen Studien als Investigator/Subinvestigator im Bereich: Nierenzellkarzinom, Prostatakarzinom, BPH, Overactie Bladder

• American Society of Clinical Oncology (ASCO)
• European Association of Urology (EAU)
• Deutsche Gesellschaft für Urologie (DGU)
• German Society of Residents in Urology (GeSRU e.V.)
• Uro-onkologischer Arbeitskreis ZUT Mannheim

• Peter Firek, David Pfister, David Thüer, Bernhard Bremer, Robin Epplen, Axel Heidenreich (2010): DOCETAXEL - RECHALLENGE AT PSA RELAPSE AFTER DOCETAXEL CHEMOTHERAPY AT HORMONE REFRACTORY PROSTATE CANCER; The Journal of Urology, Vol. 183, No. 4, Supplement, April 2010
• Peter Firek, Dorothea Rohrmann, Axel Heidenreich (2010): CONTACTLESS ENDOSCOPIC MEASUREMENT OF URINARY BLADDER WALL PERFUSION; The Journal of Urology, Vol. 183, Issue 4, Supplement, April 2010
• David Thüer, David Pfister, Peter Firek, Robin Epplen, Ketevan Toronjadze, Bernhard Bremer Axel Heidenreich (2010): THE ROLE OF PREVOIUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) ON THE ACCURACY OF NOMOGRAMS TO PREDICT FINAL PATHOLOGICAL STAGE IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER (PCA); The Journal of Urology, Vol. 183, Issue 4, Supplement, April 2010
• Peter Firek, et al. (2012): METASTASECTOMY IN RENAL CELL CANCER AFTER NEOADJUVANT THERAPIY WITH MULTI-TYROSINE KINASE INHIBITORS; Urologe A.